A significant breakthrough in cancer study is arising with the use of VHH fragments to re-engage mutated p53. This essential malignant protector protein is frequently disabled in various types of tumors, leading https://agency-social.com/story7003111/nanobodies-reactivate-p53-a-promising-pathway-for-cancer-therapy